Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 2/2007

01-02-2007 | Editorial

Invasive devices: no need? No use!

Authors: Stijn I. Blot, Renaat Peleman, Koenraad H. Vandewoude

Published in: Intensive Care Medicine | Issue 2/2007

Login to get access

Excerpt

Nosocomial infection remains the most frequent complication associated with hospitalization, presenting a serious burden in terms of health care costs, morbidity, and possibly also mortality [1, 2]. Especially intensive care unit (ICU) patients are at risk of infection because of their decreased immune status due to an often debilitated physical condition and exposure to numerous invasive procedures. Therefore surveillance of nosocomial infections is of utmost importance when considering quality control in ICUs. Strict follow-up of the incidence of some of the most prevalent infections (pneumonia, bacteremia, urinary tract infection, surgical site infection) is essential to assess the quality of infection control and to evaluate the value of interventions introduced to minimize the threat of hospital-acquired infection. …
Literature
1.
Garrouste-Orgeas M, Timsit JF, Tafflet M, Misset B, Zahar JR, Soufir L, Lazard T, Jamali S, Mourvillier B, Cohen Y, De Lassence A, Azoulay E, Cheval C, Descorps-Declere A, Adrie C, Costa de Beauregard MA, Carlet J (2006) Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis 42:1118–1126PubMedCrossRef
2.
Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH (2002) Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122:2115–2121PubMedCrossRef
3.
van der Kooi T, de Boer A, Manniën J, Wille J, Beaumont M, Mooi B, van den Hof S (2006) Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med (DOI 10.​1007/​s00134-006-0464-3)
4.
Eggimann P, Hugonnet S, Sax H, Touveneau S, Chevrolet JC, Pittet D (2003) Ventilator-associated pneumonia: caveats for benchmarking. Intensive Care Med 29:2086–2089PubMedCrossRef
5.
Mori H, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M (2006) Oral care reduces incidence of ventilator-associated pneumonia in ICU populations. Intensive Care Med 32:230–236PubMedCrossRef
6.
Safdar N, Dezfulian C, Collard HR, Saint S (2005) Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 33:2184–2193PubMedCrossRef
7.
Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, Brun-Buisson C (1998) Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 129:433–440PubMed
8.
Myny D, Depuydt P, Colardyn F, Blot S (2005) Ventilator-associated pneumonia in a tertiary care ICU: analysis of risk factors for acquisition and mortality. Acta Clin Belg 60:114–121PubMed
9.
Kress JP, Pohlman AS, O'Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342:1471–1477PubMedCrossRef
10.
Berenholtz SM, Pronovost PJ, Lipsett PA, Hobson D, Earsing K, Farley JE, Milanovich S, Garrett-Mayer E, Winters BD, Rubin HR, Dorman T, Perl TM (2004) Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 32:2014–2020PubMedCrossRef
11.
Blot S, De Bacquer D, Hoste E, Depuydt P, Vandewoude K, De Waele J, Benoit D, De Schuijmer J, Colardyn F, Vogelaers D (2005) Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients. Infect Control Hosp Epidemiol 26:352–356PubMedCrossRef
12.
Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, Decruyenaere J, Vogelaers D, Colardyn F, Vandewoude KH (2005) Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 41:1591–1598PubMedCrossRef
13.
Depuydt P, Myny D, Blot S (2006) Nosocomial pneumonia: aetiology, diagnosis and treatment. Curr Opin Pulm Med 12:192–197PubMedCrossRef
14.
Calandra T, Cohen J (2005) The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33:1538–1548PubMedCrossRef
15.
Blot S, Vandewoude K, Hoste E, Colardyn F (2003) Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa. J Hosp Infect 53:18–24PubMedCrossRef
16.
Blot S, Vandewoude K, Hoste E, De Waele J, Kint K, Rosiers F, Vogelaers D, Colardyn F (2003) Absence of excess mortality in critically ill patients with nosocomial Escherichia coli bacteremia. Infect Control Hosp Epidemiol 24:912–915PubMedCrossRef
17.
Blot SI, Vandewoude KH, Colardyn FA (2002) Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients. Eur J Clin Microbiol Infect Dis 21:471–473PubMedCrossRef
18.
Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C (1999) The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 159:1249–1256PubMed
19.
Blot SI, Vandewoude KH, Hoste EA, Colardyn FA (2002) Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 113:480–485PubMedCrossRef
20.
Girou E, Stephan F, Novara A, Safar M, Fagon JY (1998) Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med 157:1151–1158PubMed
21.
Lodise TP, McKinnon PS, Tam VH, Rybak MJ (2002) Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clin Infect Dis 34:922–929PubMedCrossRef
22.
Blot S, Vandewoude K, Colardyn F (2003) Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 29:471–475PubMed
23.
Leleu G, Aegerter P, Guidet B (2002) Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 17:168–175PubMedCrossRef
24.
Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598–1601PubMedCrossRef
25.
Rello J, Sole-Violan J, Sa-Borges M, Garnacho-Montero J, Munoz E, Sirgo G, Olona M, Diaz E (2005) Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides. Crit Care Med 33:1983–1987PubMedCrossRef
26.
Blot S, Vandewoude K (2004) Early detection of systemic infection. Acta Clin Belg 59:20–23PubMed
27.
Colardyn F (2005) Appropriate and timely empirical antimicrobial treatment of icu infections-a role for carbapenems. Acta Clin Belg 60:51–62PubMed
28.
Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D (2003) Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115:529–535PubMedCrossRef
29.
Pea F, Viale P (2006) The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? Clin Infect Dis 42:1764–1771PubMedCrossRef
30.
Rossi C, Simini B, Brazzi L, Rossi G, Radrizzani D, Iapichino G, Bertolini G (2006) Variable costs of ICU patients: a multicenter prospective study. Intensive Care Med 32:545–552PubMedCrossRef
Metadata
Title
Invasive devices: no need? No use!
Authors
Stijn I. Blot
Renaat Peleman
Koenraad H. Vandewoude
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 2/2007
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-006-0465-2

Other articles of this Issue 2/2007

Intensive Care Medicine 2/2007 Go to the issue

Review

Posterior reversible encephalopathy syndrome in intensive care medicine

EXPERIMENTAL

Effects of vaporized perfluorohexane and partial liquid ventilation on regional distribution of alveolar damage in experimental lung injury

Correspondence

Novel indications for the Boussignac CPAP valve

Experimental

Plasma volume expansion of 5% albumin, 4% gelatin, 6% HES 130/0.4, and normal saline under increased microvascular permeability in the rat

Original

Continuous cerebral autoregulation monitoring by improved cross-correlation analysis: comparison with the cuff deflation test

Original

Serum S-100B protein monitoring in patients with severe traumatic brain injury